Amyloid oligomers: A joint experimental/computational perspective on Alzheimer's disease, Parkinson's disease, type II diabetes, and amyotrophic lateral sclerosis

PH Nguyen, A Ramamoorthy, BR Sahoo… - Chemical …, 2021 - ACS Publications
Protein misfolding and aggregation is observed in many amyloidogenic diseases affecting
either the central nervous system or a variety of peripheral tissues. Structural and dynamic …

Metal ions in Alzheimer's disease: a key role or not?

Y Liu, M Nguyen, A Robert… - Accounts of chemical …, 2019 - ACS Publications
Conspectus Despite tremendous research efforts in universities and pharmaceutical
companies, effective drugs are still lacking for the treatment of Alzheimer's disease (AD). The …

Function and toxicity of amyloid beta and recent therapeutic interventions targeting amyloid beta in Alzheimer's disease

K Rajasekhar, M Chakrabarti… - Chemical …, 2015 - pubs.rsc.org
Amyloidogenesis has been implicated in a broad spectrum of diseases in which amyloid
protein is invariably misfolded and deposited in cells and organs. Alzheimer's disease is one …

Molecular structure of Cu (II)-bound amyloid-β monomer implicated in inhibition of peptide self-assembly in Alzheimer's disease

A Abelein, S Ciofi-Baffoni, C Mörman, R Kumar… - JACS Au, 2022 - ACS Publications
Metal ions, such as copper and zinc ions, have been shown to strongly modulate the self-
assembly of the amyloid-β (Aβ) peptide into insoluble fibrils, and elevated concentrations of …

Regulation of copper and iron homeostasis by metal chelators: A possible chemotherapy for Alzheimer's disease

A Robert, Y Liu, M Nguyen… - Accounts of chemical …, 2015 - ACS Publications
Conspectus With the increase of life expectancy of humans in more than two-thirds of the
countries in the World, aging diseases are becoming the frontline health problems …

Role of metal cations of copper, Iron, and aluminum and multifunctional ligands in Alzheimer's disease: Experimental and computational insights

N Puentes-Díaz, D Chaparro, D Morales-Morales… - ACS …, 2023 - ACS Publications
Alzheimer's disease (AD) is the most common form of dementia, affecting millions of people
around the world. Even though the causes of AD are not completely understood due to its …

Multifunctional nanocarriers for Alzheimer's disease: befriending the barriers

MA Ansari, T Tripathi, B Venkidasamy, A Monziani… - Molecular …, 2024 - Springer
Neurodegenerative diseases (NDDs) have been increasing in incidence in recent years and
are now widespread worldwide. Neuronal death is defined as the progressive loss of …

Identification of key structural features of the elusive Cu–Aβ complex that generates ROS in Alzheimer's disease

C Cheignon, M Jones, E Atrián-Blasco, I Kieffer… - Chemical …, 2017 - pubs.rsc.org
Oxidative stress is linked to the etiology of Alzheimer's disease (AD), the most common
cause of dementia in the elderly. Redox active metal ions such as copper catalyze the …

A Water‐Soluble Peptoid Chelator that Can Remove Cu2+ from Amyloid‐β Peptides and Stop the Formation of Reactive Oxygen Species Associated with Alzheimer's …

AE Behar, L Sabater, M Baskin, C Hureau… - Angewandte …, 2021 - Wiley Online Library
Cu bound to amyloid‐β (Aβ) peptides can act as a catalyst for the formation of reactive
oxygen species (ROS), leading to neuropathologic degradation associated with Alzheimer's …

Multi-target-directed phenol–triazole ligands as therapeutic agents for Alzheimer's disease

MR Jones, E Mathieu, C Dyrager, S Faissner… - Chemical …, 2017 - pubs.rsc.org
Alzheimer's disease (AD) is a multifactorial disease that is characterized by the formation of
intracellular neurofibrillary tangles and extracellular amyloid-β (Aβ) plaque deposits …